- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x K: POTASSIUM ION(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.5: 11 residues within 4Å:- Chain A: R.3, V.6, R.7, L.11, F.238, V.242, F.246
- Chain B: L.115, L.116, P.119, V.123
12 PLIP interactions:9 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:V.6, A:R.7, A:F.238, A:V.242, A:F.246, A:F.246, A:F.246, B:L.115, B:L.116, B:V.123
- Salt bridges: A:R.3, A:R.7
Y01.9: 12 residues within 4Å:- Chain A: L.115, L.116, P.119, L.120, V.123
- Chain B: R.3, V.6, R.7, L.11, F.238, V.242, F.246
13 PLIP interactions:8 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:V.6, B:R.7, B:V.242, B:F.246, B:F.246, B:F.246, A:L.115, A:L.116, A:L.120, A:L.120, A:V.123
- Salt bridges: B:R.3, B:R.7
Y01.10: 10 residues within 4Å:- Chain A: F.16
- Chain B: R.79, F.80, A.81, F.84, Q.215, P.218, V.221, A.222, F.225
13 PLIP interactions:11 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.80, B:A.81, B:F.84, B:V.221, B:A.222, B:F.225, B:F.225, A:F.16, A:F.16
- Hydrogen bonds: B:F.80, B:A.81, B:Q.215
- Salt bridges: B:R.79
- 1 x KKQ: [4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(2-fluorophenyl)methanone(Non-covalent)
KKQ.6: 23 residues within 4Å:- Chain A: I.91, T.92, T.93, T.121, L.122, F.125, L.197, T.198, T.199, L.232, I.235, L.239
- Chain B: T.92, T.93, I.118, L.122, F.125, L.197, T.199, L.232, I.235, G.236, L.239
11 PLIP interactions:5 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:I.118, B:L.122, B:T.199, B:I.235, B:L.239, A:T.121, A:L.122, A:F.125, A:L.232, A:I.235, A:L.239
- 2 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
DMU.7: 5 residues within 4Å:- Chain A: R.131, I.132, T.134, L.135
- Chain B: E.254
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:R.131, A:I.132, A:L.135
DMU.11: 4 residues within 4Å:- Chain A: E.254
- Chain B: R.131, L.135, Y.138
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:R.131, B:L.135, B:L.135
- 2 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.8: 7 residues within 4Å:- Chain A: G.105, V.108, F.112
- Chain B: V.25, A.28, L.29, E.32
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:V.108, A:F.112, B:V.25
PC1.12: 4 residues within 4Å:- Chain A: L.29
- Chain B: G.105, V.108, F.112
5 PLIP interactions:1 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:L.29, B:V.108, B:F.112, B:F.112, B:F.112
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rodstrom, K.E.J. et al., A lower X-gate in TASK channels traps inhibitors within the vestibule. Nature (2020)
- Release Date
- 2019-08-07
- Peptides
- Potassium channel subfamily K member 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x K: POTASSIUM ION(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 1 x KKQ: [4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(2-fluorophenyl)methanone(Non-covalent)
- 2 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
- 2 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rodstrom, K.E.J. et al., A lower X-gate in TASK channels traps inhibitors within the vestibule. Nature (2020)
- Release Date
- 2019-08-07
- Peptides
- Potassium channel subfamily K member 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D - Membrane
-
We predict this structure to be a membrane protein.